SHA:688266 Revenue

In the year 2025, Suzhou Zelgen Biopharmaceuticals had annual revenue of 810.48M CNY with 52.07% growth. Suzhou Zelgen Biopharmaceuticals had revenue of 217.04M in the quarter ending December 31, 2025, with 45.83% growth.

Revenue

810.48M

Revenue Growth

+52.07%

P/S Ratio

32.47

Revenue / Employee

768.23K

Employees

1,055

Market Cap

26.32B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	810.48M	277.53M	52.07%
Dec 31, 2024	532.95M	146.52M	37.91%
Dec 31, 2023	386.44M	84.13M	27.83%
Dec 31, 2022	302.31M	111.94M	58.81%
Dec 31, 2021	190.36M	162.70M	588.19%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Hualan Biological Engineering	4.49B
BrightGene Bio-Medical Technology	1.22B
Beijing Tiantan Biological Products	6.17B
Xiamen Amoytop Biotech	3.70B
Yili Chuanning Biotechnology	4.41B
Chongqing Zhifei Biological Products	8.75B
Shanghai RAAS Blood Products	7.35B
Sinocelltech Group	1.56B

Revenue Rankings